Skip to content

Haemonetics HAE Tax on Share Settlement

Tax on Share Settlement at other companies

ICU Medical logo
ICU MedicalICUI
$38.78M+362%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$19M-32.1%
ITG
Integer HoldingsITGR
$9.04M-36.1%
Repligen logo
RepligenRGEN
$5.54M-14.6%
TEC
Bio-TechneTECH
$157K-46.0%

Other financials

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%
Operating income$67.4M+14.2%
Net income$44.7M+19.3%
EPS (diluted)$0.95+28.4%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total debt$1.3B-0.7%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
CapEx$17.7M+12.9%
Free cash flow$53.3M-47.2%

Valuation

See full
Market cap$3.31B-18.0%

Profitability

See full
Gross margin59%+4.0pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin19.5%+9.1pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.6×0.0×
Current ratio+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's tax on share settlement.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Haemonetics's tax on share settlement?
Haemonetics (HAE) reported tax on share settlement of $46K in Q1 2026.
What does tax on share settlement mean?
Cash paid to tax authorities for employee share vesting, where the company withholds shares and pays the tax obligation in cash.